Additive benefits of dapagliflozin to sacubitril/valsartan in cardiometabolic age-related cardiac dysfunction involve endothelial oxidative defense and senescence
31 August 2025 (17:15 - 18:00)
Organised by: 
About the speaker
University of Naples Federico II, Naples (Italy)
9 More presentations in this session
Doctor J. Noiri (Kobe, JP)
Doctor B. Dal Passo (Ferrara, IT)
Professor O. Hanon (Paris, FR)
Access the full session
The Event
ESC Congress 2025
31 August 2025
17:15 CET
You may be interested in
Congress Session
